Denmark BioInnovation Institute (BII)

Denmark BioInnovation Institute sits under the Novo Nordisk Foundation as a rolling funding route for early-stage life science and deeptech projects. The foundation itself is an independent Danish enterprise foundation founded in 1922, with work spanning health, sustainability, and the broader life science ecosystem. BII inherits that mission by backing projects that can move scientific promise toward a commercial path. The program offers DKK 500,000 to DKK 3 million, with a median award of about DKK 1.5 million. It is open to for-profit applicants from Denmark or the international life science space, targets projects at TRL 2 to 5, and does not require match funding. The cadence is rolling, so timing matters less than whether the project is ready and the team is structured as a company or company-forming venture. That makes it a fit for teams that already have a company structure and a project that can move from scientific promise toward a venture-ready plan. The strongest submissions will be narrow, technically grounded, and obviously aligned with life science or deeptech rather than a broad commercial story. In practice, the route favors early-stage builders who can show both scientific credibility and a realistic path to company development.

No upcoming rounds verified. Cadence: Rolling.